# A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSIS

> **NCT05372575** · NA · COMPLETED · sponsor: **Pfizer** · enrollment: 300 (actual)

## Conditions studied

- Immunogenicity, Vaccine

## Interventions

- **BIOLOGICAL:** PCV13 PAC study

## Key facts

- **NCT ID:** NCT05372575
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-15
- **Primary completion:** 2021-12-14
- **Final completion:** 2021-12-14
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2023-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05372575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05372575, "A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSIS". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05372575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*